The competitive inhibition of C-II dependent lipoprotein lipase activity by heparin.
D000818:Animals; D053304:Apolipoprotein C-II; D001053:Apolipoproteins / Q000494:pharmacology; D001056:Apolipoproteins C / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D001667:Binding, Competitive; D002417:Cattle; D004789:Enzyme Activation / Q000187:drug effects; D006170:Gum Arabic / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology*; D007700:Kinetics; D008071:Lipoprotein Lipase / Q000302:isolation & purification / Q000378:metabolism*; D008079:Lipoproteins, VLDL / Q000494:pharmacology; D008894:Milk Proteins / Q000302:isolation & purification / Q000378:metabolism; D017830:Octoxynol; D011092:Polyethylene Glycols / Q000494:pharmacology
D053304:Apolipoprotein C-II; D001053:Apolipoproteins; D001056:Apolipoproteins C; D008079:Lipoproteins, VLDL; D008894:Milk Proteins; C027610:apolipoprotein VLDL II; D011092:Polyethylene Glycols; D006170:Gum Arabic; D017830:Octoxynol; D006493:Heparin; D008071:Lipoprotein Lipase